Erchonia Corporation Laser Saves Diabetic's Foot

For Information Contact: 
Erchonia Corporation
2021 Commerce Dr
McKinney, TX  75071
ATT: Charlie Shanks
VP, Sales and Marketing 
214.733.5203
cshanks@erchonia.com 

FOR IMMEDIATE RELEASE:

Mesa, AZ, APRIL 13, 2005
- After surgically removing the gangrenous area that destroyed a significant portion of the patients' foot, the doctors tried the non-invasive laser treatment in a last ditch effort to preserve the foot. The laser treatment was surprisingly effective. Although the man lost a portion of one toe, his foot was returned to near-normal appearance and functionality.

"The transformation was dramatic," said Charlie Shanks, Vice President of Sales and Marketing for Erchonia Medical. "This was a powerful demonstration of the healing potential of Erchonia low-level laser treatment. For those diabetics facing the loss of a limb due to advanced tissue decay, the implications of laser treatment are profound." Dr. Robert Jackson of Marion, Indiana performed the surgery, using a laser that was donated by Erchonia for research.

The Erchonia laser has established its effectiveness in the field of sports medicine, enabling injured athletes or those undergoing surgery to get back into action far sooner than they would without the treatment. In addition, the Erchonia Neira 4L(TM) laser recently received FDA approval for use during liposuction. Extensive study demonstrated that those patients actively treated with the laser endured significantly less pain than placebo-treated subjects.

By contrast to the high-power, high-heat lasers that are used in various surgical procedures, Erchonia lasers produce a low-level, or cold, output that has no thermal effect on the body's tissue. Instead, the laser serves to stimulate biological function positively. Low-level laser therapy is commonly used to treat conditions such as acute and chronic pain in a number of medical areas without negative side effects. The painless, non-invasive laser promotes healing, as shown in the treatment of the diabetic patient's decayed foot. 

About Erchonia
Erchonia was founded in 1996 and is dedicated to advancing healing and health through the scientific development of superior bio-medical laser products. Recently, Erchonia moved into new, state-of-art facilities that permit the cycle of research, development, production fabrication and final assembly to be accomplished in-house. To learn more about Erchonia lasers and the surgeons who use them, go on line at www.erchonia.com.